COPD

May 13, 2015November 9, 2015

Draft Opinion released by the European Medicines Agency on Two Patient-Reported Outcome (PRO) tools for COPD treatments evaluation

COPD, News

Evidera, a biotechnology company that provides solutions based on current evidence for the healthcare industry, recently announced the release of a draft qualification opinion of the European Medicines Agency’s (EMA) regarding two ... Read more

May 12, 2015November 9, 2015

NLRX1 Identified As Crucial Checkpoint In COPD Lung Damage

COPD, News

Scientists from Brown and Yale University have uncovered a new mitochondrial pathway whose expression acts as a switch that triggers Chronic Obstructive Pulmonary Disease (COPD) in patients. COPD is the third largest ... Read more

May 11, 2015November 9, 2015

Protein Found to Play a Key Role in COPD-Related Lung Damage Due to Cigarette Smoke and Viral Infection

COPD, Emphysema, News

Researchers at Yale University in Connecticut and Brown University in Rhode Island recently discovered that a particular protein called interleukin-15 (IL-15) plays a key role in the induction of lung damage caused by cigarette ... Read more

May 11, 2015November 9, 2015

Cystic Fibrosis And COPD Specialist Firm Spyryx Biosciences Announces $18 Million Series A Funding

COPD, Cystic Fibrosis, News

Spyryx Biosciences Inc., a privately-held biopharmaceutical company specializing in development of novel therapeutics for respiratory diseases, including cystic fibrosis (CF) and chronic obstructive pulmonary disorder (COPD), announced Thursday that it ... Read more

May 11, 2015November 9, 2015

Anemia in COPD Found To Be a Risk Factor For Poorer Exercise Capacity, Quality of Life and Hemoglobin Serum Levels

COPD, News

In a recent study published in the journal BMC Pulmonary Medicine, researchers from Italy found that anemia in COPD is a risk factor for poorer exercise capacity and quality of ... Read more

May 7, 2015November 9, 2015

Arrowhead Initiates Transition to Patients in Phase 1 Study for Alpha-1 Antitrypsin Deficiency Therapy

COPD, News

Arrowhead Research Corporation a biopharmaceutical company that develops targeted RNAi therapeutics, recently announced that they have completed dosing in healthy volunteers and will now start dosing patients in an on-going ... Read more

May 7, 2015November 9, 2015

New Insights Into How Cigarette Smoke Increases Inflammation In Lung Cells

COPD, News

In a recent study entitled “Decreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression” researchers show that ... Read more

May 6, 2015November 9, 2015

Aeolus Announces Positive Data on AEOL 10150 in Lung Injury Survival Rates

COPD, News

Aeolus Pharmaceuticals, Inc., a biotechnology firm funded mainly by the U.S. government, is developing a new class of broad-spectrum, catalytic-antioxidant compounds that protect healthy tissue from the damaging effects of radiation. ... Read more

May 5, 2015November 9, 2015

Cigarette Smoke Analysis Leads To Potential Therapeutic Target For COPD

COPD

A new study led by researchers at Yale School of Medicine in Connecticut and Brown University in Rhode Island recently revealed that cigarette smoke interferes with a specific protein that ... Read more

May 5, 2015November 9, 2015

3D Human Lung Tissue Cultures Used to Test COPD Therapeutics

COPD, News

In a recent study entitled “Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures,” researchers developed ex vivo 3D human lung tissue cultures (3D-LTCs) to determine ... Read more